Floatz logo

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER

Juvenile Idiopathic Arthritis

Duke Universityprotein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Juvenile Idiopathic Arthritis cohort.

Asset / SponsorPhaseRating
METHOTREXATE
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
MODERNA COVID-19 VACCINE RNA
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
FILGRASTIM
Paul Szabolcs
Phase 2CCC
Cyclophosphamide
Paul Szabolcs
Phase 2CCC
Fludarabine
Paul Szabolcs
Phase 2CCC

View all 18 →

Same molecule, other indications

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER is also rated in:

psoriasisDormant
BBB
Indicative ·
76 / 100
View asset →
Pancreatitis, Chronic; Diabetes; TransplantDormant
BB
Indicative ·
68 / 100
View asset →
skin carcinomaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →